litlas
Log inCreate account

Charles A. Boucher

Active 1978–2023

Also published as
CHARLES A. BOUCHER
142
Papers
24,134
Citations
91
h-index
138
i10-index

Citations

Citations per year for Charles A. Boucher1980: 5 citations1981: 11 citations1982: 15 citations1983: 12 citations1984: 17 citations1985: 23 citations1986: 34 citations1987: 34 citations1988: 48 citations1989: 39 citations1990: 84 citations1991: 79 citations1992: 103 citations1993: 105 citations1994: 78 citations1995: 123 citations1996: 128 citations1997: 147 citations1998: 204 citations1999: 192 citations2000: 182 citations2001: 153 citations2002: 170 citations2003: 142 citations2004: 150 citations2005: 124 citations2006: 126 citations2007: 137 citations2008: 158 citations2009: 166 citations2010: 148 citations2011: 170 citations2012: 140 citations2013: 134 citations2014: 87 citations2015: 86 citations2016: 69 citations2017: 47 citations2018: 60 citations2019: 307 citations2020: 324 citations2021: 405 citations2022: 239 citations2023: 112 citations2024: 184 citations2025: 57 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,087 citing papers, 29.8% of this breakdownUnited Kingdom: 503 citing papers, 7.2% of this breakdownNetherlands: 460 citing papers, 6.6% of this breakdownCanada: 297 citing papers, 4.2% of this breakdownFrance: 295 citing papers, 4.2% of this breakdownGermany: 287 citing papers, 4.1% of this breakdownChina: 256 citing papers, 3.6% of this breakdownItaly: 221 citing papers, 3.2% of this breakdownSwitzerland: 207 citing papers, 3% of this breakdownSpain: 206 citing papers, 2.9% of this breakdownAustralia: 187 citing papers, 2.7% of this breakdownBelgium: 142 citing papers, 2% of this breakdown
0%29.8%Other 26.5%

Institutions

Fields

  • Medicine71.1%
  • Immunology and Microbiology17.9%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Computer Science1.8%
  • Mathematics0.8%
  • Agricultural and Biological Sciences0.7%
  • Other2.6%

Topics

  • HIV Research and Treatment12.3%
  • HIV/AIDS drug development and treatment11.3%
  • HIV/AIDS Research and Interventions7.7%
  • Hepatitis C virus research3.1%
  • Cardiac Imaging and Diagnostics2.9%
  • Influenza Virus Research Studies2.7%
  • Other60%

Coauthors

All papers

Open in search
  1. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

    Authors: Elisa De Crignis, Tanvir Hossain, Shahla Romal, Fabrizia Carofiglio, Panagiotis Moulos, Mir M. Khalid, Shringar Rao, Ameneh Bazrafshan, Monique M.A. Verstegen, Farzin Pourfarzad, Christina Koutsothanassis, Helmuth Gehart, Tsung Wai Kan, Robert‐Jan Palstra, Charles A. Boucher, Jan N.M. IJzermans, Meritxell Huch, Sylvia F. Boj, Robert G.J. Vries, Hans Clevers, Luc J. W. van der Laan, Pantelis Hatzis, Tokameh Mahmoudi - eLife 2021 cited by 132

  2. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

    Authors: Jeroen J. A. van Kampen, David van de Vijver, Pieter L. A. Fraaij, Bart L. Haagmans, Mart M. Lamers, Nisreen M.A. Okba, Johannes P. C. van den Akker, Henrik Endeman, Diederik Gommers, Jan J. Cornelissen, Rogier A.S. Hoek, Menno M. van der Eerden, Dennis A. Hesselink, Herold J. Metselaar, Annelies Verbon, Jurriaan E.M. de Steenwinkel, Georgina I. Aron, Eric C. M. Van Gorp, Sander van Boheemen, Jolanda J.C. Voermans, Charles A. Boucher, Richard Molenkamp, Marion Koopmans, Corine H. GeurtsvanKessel, Annemiek A. van der Eijk - Nature Communications 2021 cited by 843

  3. Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Authors: Diane Bennett, Ricardo Camacho, Dan Oţelea, Daniel R. Kuritzkes, Hervé Fleury, Mark Kiuchi, Walid Heneine, Rami Kantor, Michael R. Jordan, Jonathan Schapiro, Anne–Mieke Vandamme, Paul Sandstrom, Charles A. Boucher, David van de Vijver, Soo‐Yon Rhee, Tommy F. Liu, Deenan Pillay, Robert W. Shafer - PLoS ONE 2009 cited by 960

  4. Quality of life among people living with HIV in England and the Netherlands: a population-based study

    Authors: Stephanie Popping, Meaghan Kall, Brooke E Nichols, Evelien Stempher, Lisbeth Versteegh, David van de Vijver, Ard van Sighem, Matthijs Versteegh, Charles A. Boucher, Valérie Delpech, Annelies Verbon - The Lancet Regional Health - Europe 2021 cited by 55

  5. Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir

    Authors: Shringar Rao, Cynthia Lungu, Raquel Crespo, Thijs H. Steijaert, Alicja Górska, Robert‐Jan Palstra, Henrieke Prins, Wilfred F. J. van IJcken, Yvonne M. Mueller, Jeroen J. A. van Kampen, Annelies Verbon, Peter D. Katsikis, Charles A. Boucher, Casper Rokx, Rob A. Gruters, Tokameh Mahmoudi - Nature Communications 2021 cited by 59

  6. HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy

    Authors: Ingeborg E A Wijting, Cynthia Lungu, Bart Rijnders, Marchina E van der Ende, Hanh Thi Pham, Thibault Mésplède, Suzan D. Pas, Jolanda J.C. Voermans, Rob Schuurman, David van de Vijver, Patrick H. M. Boers, Rob A. Gruters, Charles A. Boucher, Jeroen J. A. van Kampen - The Journal of Infectious Diseases 2018 cited by 79

  7. Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets

    Authors: Vincent J. Munster, Emmie de Wit, Judith M. A. van den Brand, Sander Herfst, Eefje J. A. Schrauwen, Theo M. Bestebroer, David van de Vijver, Charles A. Boucher, Marion Koopmans, Guus F. Rimmelzwaan, Thijs Kuiken, Albert D. M. E. Osterhaus, Ron A. M. Fouchier - Science 2009 cited by 611

  8. Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study

    Authors: Bruno Lina, Charles A. Boucher, Albert D. M. E. Osterhaus, Arnold S. Monto, Martin Schutten, Richard J. Whitley, Jonathan S. Nguyen‐Van‐Tam - Influenza and Other Respiratory Viruses 2017 cited by 98

  9. Influenza Virus Resistance to Antiviral Therapy

    Authors: Erhard van der Vries, Martin Schutten, Pieter L. A. Fraaij, Charles A. Boucher, Albert D. M. E. Osterhaus - Advances in pharmacology 2013 cited by 85

  10. Extracting causal relations on HIV drug resistance from literature

    Authors: Quoc-Chinh Bui, Breanndán Ó Nualláin, Charles A. Boucher, Peter M. A. Sloot - BMC Bioinformatics, BMC Bioinform. 2010 cited by 50

  11. Securing sustainable funding for viral hepatitis elimination plans

    Authors: Angelos Hatzakis, Jeffrey V. Lazarus, Εvangelos Cholongitas, Ricardo Baptista‐Leite, Charles A. Boucher, Cristian‐Silviu Buşoi, Sylvie Deuffic‐Burban, Jagpreet Chhatwal, Gamal Esmat, Sharon Hutchinson, M. Malliori, Mojca Matičič, Antons Mozalevskis, Francesco Negro, George A. Papandreou, George Papatheodoridis, Markus Peck‐Radosavljevic, Homie Razavi, Tatjana Reić, Eberhard Schatz, Nurdan Tözün, Zobair M. Younossi, M.P. Manns - Liver International 2019 cited by 35

  12. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

    Authors: Akhteruzzaman Molla, Marina Korneyeva, Qing Gao, Sudthida Vasavanonda, Paaline J. Schipper, Hongmei Mo, Martin Markowitz, Tatyana Chernyavskiy, Ping Niu, Nicholas A. Lyons, Ann Hsu, G. Richard Granneman, David D. Ho, Charles A. Boucher, John M. Leonard, Daniel W. Norbeck, Dale J. Kempf - Nature Medicine 1996 cited by 768

  13. Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

    Authors: Rob Schuurman, Monique Nijhuis, Remko van Leeuwen, P Schipper, Daphne de Jong, P. Collis, S. A. Danner, Jan W. Mulder, Clive Loveday, Cindy Christopherson, Shirley Kwok, John J. Sninsky, Charles A. Boucher - The Journal of Infectious Diseases 1995 cited by 517

  14. High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

    Authors: Charles A. Boucher, N. Cammack, P Schipper, Rob Schuurman, Philippa Rouse, Mark A. Wainberg, J. M. Cameron - Antimicrobial Agents and Chemotherapy 1993 cited by 319

  15. Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study

    Authors: Brooke E Nichols, Charles A. Boucher, Marc van der Valk, Bart Rijnders, David van de Vijver - The Lancet Infectious Diseases 2016 cited by 109

  16. Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases

    Authors: Monique Nijhuis, Noortje M. van Maarseveen, Charles A. Boucher - Handbook of experimental pharmacology 2008 cited by 95

  17. Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients

    Authors: Rogier A.S. Hoek, Marthe S. Paats, Suzan D. Pas, Marleen Bakker, Henk C. Hoogsteden, Charles A. Boucher, Menno M. van der Eerden - Scandinavian Journal of Infectious Diseases 2012 cited by 91

  18. H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis

    Authors: Erhard van der Vries, Patrick Collins, S.G. Vachieri, Xiaoli Xiong, Junfeng Liu, P.A. Walker, L.F. Haire, Alan Hay, Martin Schutten, Albert D. M. E. Osterhaus, S.R. Martin, Charles A. Boucher, J.J. Skehel, Steve Gamblin - PLoS Pathogens 2012 cited by 84

  19. The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals

    Authors: Stephanie Popping, Debora Bade, Charles A. Boucher, Mark van der Valk, Manal H. El‐Sayed, Olafsson Sigurour, Vana Sypsa, Timothy R. Morgan, Amiran Gamkrelidze, Constance Mukabatsinda, Sylvie Deuffic‐Burban, Michael Ninburg, Jordan J. Feld, Margaret Hellard, John Ward - Journal of Virus Eradication 2019 cited by 76

  20. An automated genotyping system for analysis of HIV-1 and other microbial sequences

    Authors: Tulio de Oliveira, Koen Deforche, Sharon Cassol, Mika Salminen, Dimitris Paraskevis, Chris Seebregts, Joke Snoeck, Estrelita J. Janse van Rensburg, Annemarie M. J. Wensing, David A. van de Vijver, Charles A. Boucher, Ricardo Camacho, Anne-Mieke Vandamme - Computer applications in the biosciences, Bioinform. 2005 cited by 500

  21. Reduced replication of 3TC‐resistant HIV‐1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

    Authors: Nicole Back, Monique Nijhuis, Wilco Keulen, Charles A. Boucher, B. O. Oude Essink, André B. P. Kuilenburg, Albert H. Gennip, Ben Berkhout - The EMBO Journal 1996 cited by 412

  22. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection

    Authors: Mette D. Hazenberg, Sigrid A. Otto, J. W. T. Cohen Stuart, Martie C. M. Verschuren, Jan C.C. Borleffs, Charles A. Boucher, Roel A. Coutinho, Joep M. A. Lange, Tobias F. Rinke de Wit, Aster Tsegaye, Jacques J. M. van Dongen, Dörte Hamann, Rob J. de Boer, Frank Miedema - Nature Medicine 2000 cited by 395

  23. Worldwide Evaluation of DNA Sequencing Approaches for Identification of Drug Resistance Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase

    Authors: Rob Schuurman, Lisa M. Demeter, Patricia Reichelderfer, Jolanda M.G.H. Tijnagel, Tom de Groot, Charles A. Boucher - Journal of Clinical Microbiology 1999 cited by 203

  24. Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus

    Authors: Erhard van der Vries, Foekje F. Stelma, Charles A. Boucher - New England Journal of Medicine 2010 cited by 188